Array
(
    [0] => stdClass Object
        (
            [id] => 1272
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => Ảnh.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2024-12-09
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2025-01-08 13:39:57
            [updated_time] => 2025-01-09 09:21:30
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Gentis-accompanies-the-journey-of-spearding-love-at-the-Gala-Seeds of Aspiration
            [title] => GENTIS Accompanies the Journey of Spreading Love at the Gala "Seeds of Aspiration"
            [description] => On the evening of December 7, 2024, the second Gala "Seeds of Aspiration" was successfully held at the Military Broadcasting and Television Center. During the event, the organizers announced and awarded the decision to support 100% of the costs for In Vitro Fertilization (IVF) under the program "Support for Infertile Soldiers - Love Spreads" for 2024 to 10 families of infertile soldiers.
            [content] => 

Immediately after the "Support for Infertile Soldiers - Love Spreads" program was widely announced in the media, many applications from military families were submitted. The expert council from the hospital and the Military Broadcasting and Television Center worked impartially, carefully reviewing each case to grant 10 families free IVF support for 2024.
The 10 selected cases for free IVF will receive 100% coverage of costs, including expenses for testing, egg stimulation, egg retrieval, embryo creation, embryo storage, and embryo transfer.
This year's gala brought a variety of emotions to the audience: from empathy with the unspoken struggles of infertility during the stage interaction with families longing for children, to the joy of finally holding their beloved children after much anticipation, showcased through the artistic program "Tears of Happiness" directed by Meritorious Artist Tu Long and performed by artists from the Military Cheo Theater.

In addition to the selected families for free IVF this year, nearly 30 military families, along with their children born from the first phase of the "Love Spreads" program, were present to inspire hope and trust among their peers, as well as express gratitude to the organizers and the medical staff who made their dreams of parenthood a reality.
The Gala "Seeds of Aspiration" this year was not just an artistic program or a simple ceremony for announcing and granting support, but also a reunion and return home—a place where the happiness of military families flourishes.
It is evident that the stories of military families receiving 100% support for IVF in 2021, 2022, and 2023 serve as a source of motivation for many other couples struggling with infertility on their journey to find their beloved children. The starting point may be incredibly challenging, seemingly leading to a point of giving up, but with love, community support, and perseverance, miracles will eventually come to these families.

GENTIS, wishing to spread the message "giving is everlasting," continues to accompany this year’s program as a sponsor, to provide additional trust and strength to military families. GENTIS hopes that this partnership will help military families remain steadfast on their arduous journey to parenthood. The starting point may be difficult, but with faith, love, and perseverance, miracles will eventually arrive for military families.
Through the Gala "Seeds of Aspiration," GENTIS aims to contribute even more to charitable efforts in the community, spreading the message "giving is everlasting" to collectively build a sustainable society and enhance the physical and intellectual well-being of the Vietnamese people.
            [content_more] => 
            [meta_title] => GENTIS Accompanies the Journey of Spreading Love at the Gala "Seeds of Aspiration"
            [meta_description] => On the evening of December 7, 2024, the second Gala "Seeds of Aspiration" was successfully held at the Military Broadcasting and Television Center. During the event, the organizers announced and awarded the decision to support 100% of the costs for In Vit
            [meta_keyword] => GENTIS
            [thumbnail_alt] => 
            [post_id] => 1272
            [category_id] => 4
        )

    [1] => stdClass Object
        (
            [id] => 1271
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => mti09930.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2024-12-30
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-12-30 16:32:34
            [updated_time] => 2025-01-02 08:56:29
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 0
            [language_code] => en
            [slug] => Genetic-counseling-and-pgt-testing-from-international-guidelines-to-clinical-practice-in-vietnam
            [title] => Genetic Counseling and PGT Testing: From International Guidelines to Clinical Practice in Vietnam
            [description] => Currently, the demand for Preimplantation Genetic Testing (PGT) among couples at high genetic risk, who wish to have healthy children, is increasing. Preimplantation Genetic Testing (PGT) was developed to screen and detect genetic abnormalities in embryos before they are implanted into the mother’s uterus.
            [content] => 
With advances in technology and testing methods, PGT continues to be developed and clinically validated, thereby improving the success rates of assisted reproductive treatments. This is especially beneficial for parents with genetic diseases, allowing them to have healthy children free from genetic disorders.
According to global publications and studies, using next-generation sequencing (NGS) technology, current PGT tests can screen for and detect abnormalities in chromosome number (aneuploidy) across 23 pairs of chromosomes, known as PGT-A, structural chromosome abnormalities (addition/deletion/duplication), known as PGT-SR, single-gene disorders, known as PGT-M, and recently, some reports have emerged regarding the development of PGT for polygenic diseases (PGT-P). As the use and complexity of preimplantation genetic testing (PGT) increases, genetic counseling has become an essential part of modern medicine. GENTIS successfully organized a scientific seminar on "Genetic Counseling and PGT Testing: From International Guidelines to Clinical Practice in Vietnam."

At the seminar, Specialist Doctor Level 1 Nguyen Van Thong,, Head of the Department of Medical Genetics at Hung Vuong Hospital, explained: "Genetic counseling is a process that provides information, support, and guidance related to genetics and genetic risk factors for individuals or families. It helps assess the likelihood of inheriting genetic diseases based on family history or genetic test results. Additionally, it provides knowledge about genetic-related diseases or conditions, such as cancer, genetic disorders, or congenital abnormalities.
Furthermore, doctors will counsel on the benefits, limitations, and risks of genetic tests to help patients make informed decisions. Once the genetic test results are available, the doctor will explain the results and their implications for personal and family health. In addition, genetic counseling also provides psychological support to help patients and families deal with worries or emotions related to the results or genetic risks. Moreover, doctors will discuss follow-up, treatment, or prevention measures based on genetic risks."

Specialist Doctor Level 1 Nguyen Van Thong, also emphasized the importance of collaboration among genetic specialists, infertility doctors, embryologists, and healthcare workers to ensure the highest efficacy in the testing process. He also shared the role of PGT in supporting couples to have healthy children by screening and detecting genetic abnormalities. Technological advancements in PGT-A/SR and PGT-M not only increase the chances of successful pregnancies but also reduce the risks of miscarriage and serious genetic diseases in the fetus.
From a clinical perspective, Dr. Le Thi Minh Chau, Head of the Infertility Department at Tu Du Hospital, shared that over the past thirty years, there have been rapid advancements in genetic testing and assisted reproductive technology, reshaping the PGT testing process. The development of whole genome amplification (WGA) tools, combined with optimized hormonal stimulation protocols and more effective cryopreservation methods, has led to more accurate diagnoses and improved clinical outcomes. Furthermore, the shift from day 3 to day 5 or early day 6 embryo biopsy has altered the timeline for a typical PGT clinical process.

Although PGT helps reduce pregnancy terminations, in cases such as families with single-gene disorders, PGT is a relevant option for preimplantation genetic diagnosis. However, PGT remains a solution that requires discussion and consensus guidelines. Some of the complexities in the IVF process are especially relevant for couples without fertility issues, including the risk of diagnostic errors, potential embryo damage from invasive procedures, and ethical concerns. Therefore, the decision to undergo PGT is complex and always involves a stressful decision-making process.
Sharing her experience with PGT testing in Europe, Prof. Dr. Francesca Spinella, Senior Medical Information Specialist at Eurofins Genoma Group and Senior Consultant at GENTIS, explained: "Preimplantation Genetic Testing is a growing trend in Europe and globally. PGT analyzes genetic abnormalities (gene level and chromosomal abnormalities) in embryos before transferring them into the mother's uterus, helping to select embryos with a high implantation potential and a good chance of producing a healthy baby. However, in Europe, only reputable tests such as PGT-A, PGT-SR, and PGT-M are accepted and widely monitored by the ESHRE PGT Consortium."
The ESHRE PGT Consortium, founded in 1997, is responsible for collecting data on the accuracy, reliability, efficacy, and safety of PGT-A, PGT-M, and PGT-SR. It also establishes minimum standards and promotes best practice guidelines. Additionally, the Consortium facilitates the exchange of ideas and perspectives among members.
At the seminar, Prof. Dr. Francesca Spinella also introduced new PGT tests being developed at Eurofins Genoma Group. She noted that Eurofins Genoma Group is researching and developing a new PGT testing package called PGT Next. PGT Next, in addition to detecting chromosomal abnormalities such as PGT-A/SR, can also detect aneuploidy, identify euploid embryos without abnormalities, even in cases of embryo morphological abnormalities.
Through the seminar "Genetic Counseling and PGT Testing: From International Guidelines to Clinical Practice in Vietnam," GENTIS hopes that attendees have gained new information and knowledge about preimplantation genetic testing (PGT) and a clearer understanding of the value and applicability of PGT tests in assisted reproduction. This will contribute to improving clinical outcomes, supporting patients in making informed decisions, and increasing the chances of successful pregnancies and healthy babies.
            [content_more] => 
            [meta_title] => Genetic Counseling and PGT Testing: From International Guidelines to Clinical Practice in Vietnam
            [meta_description] => Currently, the demand for Preimplantation Genetic Testing (PGT) among couples at high genetic risk, who wish to have healthy children, is increasing
            [meta_keyword] => GENTIS,pgt
            [thumbnail_alt] => 
            [post_id] => 1271
            [category_id] => 4
        )

    [2] => stdClass Object
        (
            [id] => 1270
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => mti09930.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2024-12-28
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-12-28 11:03:28
            [updated_time] => 2024-12-28 11:07:38
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 0
            [language_code] => en
            [slug] => Gentis-successfully-organized-the-PGT-genetic-testing-counseling-from-international-guidelines-to-clinical-practice-in-vietnam-scientific-symposium
            [title] => GENTIS successfully organized the “PGT genetic testing counseling: From international guidelines to clinical practice in Vietnam” scientific symposium.
            [description] => With the aims to help doctors and experts in the assisted reproductive field update latest knowledge and information on the applications of PGT, GENTIS had held the science symposium with the theme “PGT genetic testing counseling: From international guidelines to clinical practice in Vietnam” at Equatorial Hotel, 242 Tran Binh Trong Street, Ward 4, District 5, Ho Chi Minh City.

            [content] => 
The event, which took place on Dec.14 gathered heaps of prestigious experts in the field of reproductive assistance, both domestically and internationally. Notably, The conference had the presence of 3 chairpersons: Dr. Le Quang Thanh - Former Director of Tu Du Hospital; Assoc Prof. Dr. Hoang Thi Diem Tuyet - Director of Hung Vuong Hospital; and Dr. Pham Dinh Minh - Director of R&D Department at GENTIS.
The conference was honored to have the companions of 3 leading reporteres in the assisted reproductive field in Vietnam as well as Italy. The in-depth reports  provided comprehensive perspectives towards advancements in PGT testing

Specialist Doctor Level 1 Nguyen Van Thong, Head of the Department of Medical Genetics at Hung Vuong Hospital, shared on: “Genetic Counseling Before and After PGT Testing: Practical Experience”. Dr. Thong explained  that genetic counseling is the process of providing information, support, and guidance regarding genetics and genetic risk factors for individuals or families. This helps assess the risk of genetic diseases based on family history or genetic test results. It also involves educating patients about genetic-related conditions such as cancer, genetic disorders, or congenital abnormalities.
In addition, the counselor discusses the benefits, limitations, and risks of genetic testing to help patients make informed decisions. After receiving genetic test results, doctors explain the findings and their implications for the individual's and family's health. Furthermore, genetic counseling also provides psychological support to help patients and families cope with the concerns or emotions related to the results or genetic risks. Additionally, doctors will work with patients to discuss monitoring, treatment, or preventive measures based on genetic risks.

The presentation also highlighted the importance of collaboration between genetic experts, infertility specialists, embryologists, and healthcare professionals to ensure maximum effectiveness in the testing process. Dr. Thong further shared the role of PGT testing in helping couples have healthy children through the screening and detection of genetic abnormalities. Technological advancements in PGT-A/SR, PGT-M, and PGT-Max 1 not only increase the chances of successful pregnancy but also minimize the risks of miscarriage and severe genetic diseases in the fetus.
Assoc. Prof. Dr. Francesca Spinella, Senior Medical Information Specialist at Eurofins Genoma Group and Senior Expert Advisor at GENTIS, presented on "Advancements in PGT and Genetic Counseling." Dr. Spinella shared the latest data and trends from the ESHRE PGT Consortium, providing an in-depth view of the current status of PGT and genetic counseling for PGT testing in Europe.

Additionally, she shared experiences from the Eurofins Genoma lab with PGT-Next, an advanced technology combining genetic evaluation and DNA analysis, opening up new potential for improving clinical outcomes. She presented initial results and the potential of this test for future IVF applications.
Dr. Le Thi Minh Chau, Head of the Infertility Department at Tu Du Hospital, presented on "Screening for Genetic Abnormalities in PGT from a Clinical Perspective." In this presentation, Dr. Chau shared practical experience from clinical cases of PGT testing at Tu Du Hospital.

Dr. Chau noted that over the past thirty years, there have been rapid technological advancements in genetic testing and assisted reproduction, reshaping the PGT process. The development of whole genome amplification (WGA) tools, along with the implementation of optimized hormonal stimulation protocols and more effective cryopreservation methods, has led to more accurate diagnoses and improved clinical outcomes. Furthermore, the shift from day 3 to day 5 or early day 6 embryo biopsy has changed the timing of a typical PGT clinical process.
Although PGT helps reduce the need for pregnancy termination in certain cases, such as in families with single-gene disorders, PGT remains the only relevant choice for prenatal diagnosis. However, PGT is a solution that requires careful discussion and consensus guidelines. Among the challenges are the complexity of the IVF procedure, especially for couples with no fertility issues, the risk of misdiagnosis, potential embryo damage from invasive procedures, and some ethical concerns. Therefore, the decision to undergo PGT is complex and always involves a stressful decision-making process.
Through these three in-depth presentations and lively discussions among the chairpersons, speakers, and conference participants, GENTIS hopes that attendees gained valuable insights and the latest knowledge about Preimplantation Genetic Testing (PGT). Furthermore, it helped participants understand the value and practical applications of PGT tests in reproductive medicine, contributing to improving clinical outcomes and supporting patients in making informed decisions.

            [content_more] => 
            [meta_title] => GENTIS successfully organized the “PGT genetic testing counseling: From international guidelines to 
            [meta_description] => GENTIS had held the science symposium with the theme “PGT genetic testing counseling: From international guidelines to clinical practice in Vietnam” at Equatorial Hotel, 242 Tran Binh Trong Street, Ward 4, District 5, Ho Chi Minh City.

            [meta_keyword] => GENTIS,PGT
            [thumbnail_alt] => 
            [post_id] => 1270
            [category_id] => 4
        )

    [3] => stdClass Object
        (
            [id] => 1267
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => bf8c944f16e1acbff5f0.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-12-16
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-12-18 10:18:13
            [updated_time] => 2024-12-28 11:21:19
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Associate-Professor-Francesca-Spinella-visits-Gentis-partner-hospitals-strengthening-collaboration-and-advancing-genetic-testing-in-vietnam
            [title] => Associate Professor Francesca Spinella Visits GENTIS Partner Hospitals: Strengthening Collaboration and Advancing Genetic Testing in Vietnam
            [description] => During her visit to Vietnam, Professor Francesca Spinella (Senior Medical Information Specialist at Eurofins Genoma Group and Senior Expert Advisor to GENTIS) engaged in a series of significant activities at GENTIS and with partner institutions, including Hanoi’s Infertility and Andrology Hospital, Hanoi General Hospital, and Lac Viet Friendship Hospital. These expert meetings concluded successfully, laying the foundation for deeper, future collaboration between GENTIS, Genoma, and the partner hospitals.
            [content] => 
Professor Francesca Spinella's Official Visit to GENTIS Partner Institutions
As part of her work trip to Vietnam, Professor Francesca Spinella, accompanied by GENTIS experts, visited several prominent institutions in the field of reproductive health, including Lac Viet Friendship Hospital, Hanoi General Hospital, and Hanoi Infertility and Andrology Hospital. These hospitals are strategic partners of GENTIS in implementing and applying advanced genetic testing techniques.
The first stop for Professor Francesca Spinella and the GENTIS team was Lac Viet Friendship Hospital. Professor Ivan Reich, Director of the Vietnam IVF Center, along with the medical and lab teams, welcomed the group and held productive discussions with Professor Spinella and the GENTIS experts.
At this hospital, Professor Spinella gave a brief presentation on “Latest Updates in Genetic Testing for Reproductive Support, Sharing Experience from Europe.” She highlighted the advanced PGT (Preimplantation Genetic Testing) techniques used at Eurofins Genoma Group, offering valuable insights to doctors and enhancing their knowledge of the latest technologies. This, in turn, helps improve the quality of diagnosis and treatment for couples seeking to have children.

At Hanoi General Hospital, Professor Spinella continued to share knowledge on modern genetic methods used globally, discussing how to implement these practices in treatment. Of particular note were the latest PGT techniques for screening genetic abnormalities before in vitro fertilization (IVF). This is crucial as demand for reproductive healthcare rises, with more couples aiming for healthy children, especially those dealing with genetic conditions. The session was well-received by the leadership and medical staff at the Hanoi IVF Center.
The final visit for the GENTIS delegation was to Hanoi Infertility and Andrology Hospital. There, Professor Spinella and the GENTIS team conducted a direct expert exchange on pre-implantation genetic testing (PGT) packages and addressed numerous questions from the medical staff. The meeting provided fresh perspectives to doctors, helping them enhance their expertise in patient counseling and treatment.
After these visits, Professor Francesca Spinella expressed her admiration and positive impressions of the professional standards, systematic investment, and the noble mission of the hospitals in Vietnam. She also extended her gratitude to the representatives of the institutions for their warm and thoughtful reception.
The Importance of Collaboration between GENTIS and Vietnamese Hospitals
Professor Spinella’s visit to Vietnam provided an excellent opportunity for GENTIS and partner hospital doctors and experts to access advanced knowledge in reproductive support, and opened the door to long-term collaboration. With the mission of "Enhancing the physical and intellectual well-being of the Vietnamese people," GENTIS is committed to supporting partner hospitals in Vietnam by boosting professional capabilities, improving treatment quality, and increasing success rates in infertility treatment. With the backing of top experts, GENTIS pledges to stand by Vietnamese hospitals and families as they pursue their dreams of parenthood.
            [content_more] => 
            [meta_title] => Associate Professor Francesca Spinella Visits GENTIS Partner Hospitals: Strengthening Collaboration 
            [meta_description] => During her visit to Vietnam, Professor Francesca Spinella (Senior Medical Information Specialist at Eurofins Genoma Group and Senior Expert Advisor to GENTIS) engaged in a series of significant activities at GENTIS and with partner institutions
            [meta_keyword] => gentis,pgt
            [thumbnail_alt] => 
            [post_id] => 1267
            [category_id] => 4
        )

    [4] => stdClass Object
        (
            [id] => 1266
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 85b7bab01dd2a08cf9c3.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-12-17
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-12-18 08:59:53
            [updated_time] => 2024-12-18 09:02:10
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => https://gentis.com.vn/tin-tuc-c4/gentis-duoc-cuc-thue-thanh-pho-ha-noi-tuyen-duong-doanh-nghiep-nop-thue-tieu-bieu-thu-do-nam-2023-d1266
            [title] => GENTIS was honored by the Hanoi Tax Department as an outstanding tax-paying enterprise in the capital in 2023
            [description] => On the morning of December 17, Genetic Testing Service Joint Stock Company (GENTIS) was honored by the Hanoi Tax Department as an outstanding tax-paying enterprise in the capital in 2023.
            [content] => 
The conference "Commending Typical Taxpayers of the Capital in 2023" was solemnly held by the Hanoi Tax Department to honor organizations and individuals in Hanoi who have made efforts to overcome many challenges, maintain and stabilize effective production and business along with good implementation of tax policies and laws, contributing to the completion of the State budget revenue estimate while promoting the emulation movement in the capital.

GENTIS has passed the strict assessment criteria for good compliance with tax laws, efforts to overcome difficulties and made great contributions to the State budget.
With good implementation of tax policies and laws, at the Conference "Commending Typical Taxpayers of the Capital in 2023", GENTIS was honored to receive a Certificate of Merit from the Director of the Hanoi Tax Department. Established in 2010, GENTIS always respects and upholds the principles of the rule of law and sustainable development. Operating based on 5 core values: prestige, creativity, dedication, respect, continuous learning, GENTIS has increasingly improved its position in the field of genetic analysis, bringing many job opportunities for employees, contributing to the innovation and development of the country's economy.
The Certificate of Merit for Outstanding Taxpayers of the Capital is a testament to GENTIS's business efforts and a recognition of the Company's positive contributions to the construction and development of the economy and society.

This special award from the Hanoi Tax Department is a great honor and encouragement for the Board of Directors, officers and employees of GENTIS Company in working together to overcome the difficult challenges, continue to fulfill tax obligations and become a model citizen enterprise of the capital Hanoi.
            [content_more] => 
            [meta_title] => GENTIS was honored by the Hanoi Tax Department as an outstanding tax-paying enterprise in the capita
            [meta_description] => On the morning of December 17, GENTIS was honored by the Hanoi Tax Department as an outstanding tax-paying enterprise in the capital in 2023.
            [meta_keyword] => 
            [thumbnail_alt] => 
            [post_id] => 1266
            [category_id] => 4
        )

    [5] => stdClass Object
        (
            [id] => 1265
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => gentis-9.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-12-10
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-12-13 10:38:05
            [updated_time] => 2024-12-13 10:42:12
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => https://gentis.com.vn/tin-tuc-c4/ung-dung-cac-xet-nghiem-di-truyen-nham-nang-cao-hieu-qua-kham-dieu-tri-ho-tro-sinh-san-d1265
            [title] => Genetic test applications in enhancing the effectiveness in assisted reproductive examinations and treatments 
            [description] => Genetic tests play a crucial role in determining infertility causes and assisted reproduction treatments. In Vietnam, GENTIS has acquired many achievements in researching and developing advanced genetic tests, positively benefiting the patients as well as enhancing the effectiveness in assisted reproductive treatments. 
            [content] => 
Genetic roles in assisted reproduction
According to the World Health Organization’s statistics, infertility affects approximately 10% of couples of productive age. WHO has also pointed out that Vietnam is among the nations having the highest infertility rate in the world, in which 50% are those under 30. In Vietnam, It is estimated that 1 million couples face with infertility annually, accounting 7,7%
The infertility rate is equally 40% for male and female, 10% for both spouses, and 10% with unidentified causes. This phenomenon indicates that infertility can be attributed to both male and females. 

Dr. Pham Dinh Minh presented the report “Researching and applying genetic tests in enhancing the effectiveness in assisted reproduction examinations and treatments in Vietnam”

In addition to causes such as pathology, environment, and lifestyle; Genetics and abnormalities due to mutations in genes also cause infertility. Presenting at the 5th annual science conference HASAM 2024, Dr. Pham Dinh Minh (Director of R&D department at GENTIS) revealed “Genetics is involved in virtually all assisted reproductive processes, facilitating the diagnosis of genetic pathologies and their prevention in subsequent generations, determining and diagnosis of infertility’s root causes, recurrent miscarriages, and supporting reproductive enhancement. Notably, the collaboration between genetic geneticists and clinicians, along with embryologists, contributes to establishing precise diagnoses and the most suitable, effective, and optimal assisted reproduction treatment strategies for patients”. 

According to the experts, genetic screening before embryo transfer is an essential breakthrough in the assisted reproduction field. Preimplantation Genetic Testing/ PGT analyzes genetic abnormalities ( in gene and chromosome level ) in embryos before being transferred into the mother’s uterus. 

Associate Professor Francesca Spinella presented the report: “Advances in Preimplantation Genetic Screening: A European Perspective and Data from the European Society for Human Reproduction and Embryology (ESHRE) PGT Consortium.”


Sharing about advancements in preimplantation genetic screening in Europe, Senior Expert Advisor of GENTIS - Assoc Prof. Dr. Francesca Spinella (Former president of the ESHRE PGT Consortium and Senior Medical Information Specialist at Eurofins Genoma Group) noted “There are 3 traditional types of preimplantation genetic testing (PGT) commonly used: PGT-A, PGT-SR, and PGT-M. In which, PGT-A helps identify euploid and aneuploid embryos, thus increasing the chances of success in in vitro fertilization (IVF). PGT-SR can detect structural abnormalities larger than 5Mb, allowing for the selection of normal embryos, thereby improving the likelihood of achieving a successful pregnancy. PGT-M is used to screen for single-gene inherited diseases, ensuring that only embryos free from genetic mutations are selected for transfer”.
Currently, Eurofines Genoma Group is researching and developing new PGT testing packages namely niPGT-A and PGT Next. NiPGT-A is a non-invasive PGT-A test performed on the used culture medium. Notably, PGT Next can detect chromosomal abnormalities, both number and structure, like PGT-A/SR, but it also has the capability to detect polyploidy and identify diploid embryos without abnormalities, even in cases of morphological abnormalities,” added Assoc Prof. Dr. Francesca Spinella.
GENTIS's Ecosystem of Genetic Tests in Reproductive Medicine
The presentation “Research and Application of New Genetic and Genomic Tests to Improve Reproductive Health Diagnosis and Treatment in Vietnam” by Dr. Pham Dinh Minh (Director of R&D at GENTIS) drew significant attention at the HASAM 2024 Annual Scientific Conference. Dr. Minh's report highlighted how modern genetic testing technologies have benefited patients and improved the effectiveness of reproductive treatments.

Eurofins Genoma Collaborates with GENTIS to Develop Advanced Genetic Testing Technologies
The report “Researching and applying new genetic tests to enhance the effectiveness in assisted reproductive examinations and treatments” performed by Dr. Pham Dinh Minh (Director of R&D department at GENTIS) had drawn huge attention from delegates at the HASAM 2024 conference. Dr. Minh’s report pointed out that advanced genetic tests have benefited patients as well as enhanced the effectiveness in assisted reproductive treatments. 

GENTIS is proud to be a leading Genetic Testing Center in Vietnam with state-of-the-art equipment. Notably, GENTIS is also the first genetic testing facility in Vietnam to achieve international standards – ISO 15189:2022 accredited by BoA and ISO/IEC 27001:2022 accredited by GICG, while fully complying with the strict regulations of the Ministry of Health and international external quality control programs.
Currently, GENTIS offers a complete ecosystem of genetic tests for reproductive support, including tests for parents, embryos, and conditions for embryo transfer; as well as tests for maternal health and pregnancy. These specialized tests help identify the causes of infertility in both men and women, screen for genetic abnormalities, prevent rare diseases in preimplantation embryos, and support embryo transfer and pregnancy monitoring. Conducting these in-depth tests enables clinicians to provide effective treatment solutions, helping to make the dream of parenthood a reality for many families facing infertility challenges.
            [content_more] => 
            [meta_title] => Genetic test applications in enhancing the effectiveness in assisted reproductive examinations and t
            [meta_description] => In Vietnam, GENTIS has acquired many achievements in researching and developing advanced genetic tests, positively benefiting the patients.
            [meta_keyword] => gentis
            [thumbnail_alt] => 
            [post_id] => 1265
            [category_id] => 4
        )

    [6] => stdClass Object
        (
            [id] => 1264
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 600x400-web.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2024-12-11
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-12-11 10:21:44
            [updated_time] => 2024-12-11 11:15:23
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 0
            [language_code] => en
            [slug] => 5-types-of-diseases-in-children-that-can-be-detected-through-newborn-screening
            [title] => 5 Types of Diseases in Children That Can Be Detected Through Newborn Screening
            [description] => Newborn screening is a test conducted to detect conditions that may affect a child's physical and mental health and development in the future. Let’s explore 5 types of diseases that can be detected early through newborn screening.

            [content] => 

1. The Importance of Newborn Screening Tests
Genetic, endocrine, and metabolic disorders are factors that impact both the physical and mental development of children. Typically, these conditions are hard to detect in newborns because they do not exhibit clear or specific symptoms. However, if not detected early, these diseases can lead to serious consequences for both the child and the family. Therefore, conducting early newborn screening is crucial to ensure the comprehensive development of infants.
2. When to Perform Newborn Screening for Children
Newborn screening tests (NBST) are recommended to be carried out early, ideally within 2 to 7 days of birth, with the golden time for testing being 48 hours after birth. The earlier the test is conducted, the higher the chances of recovery and development, as some diseases, if detected too late, may result in irreversible damage to the child.
3. 5 Diseases Detected Through Newborn Screening
3.1 Congenital Hypothyroidism 
Congenital hypothyroidism is a thyroid disorder where a newborn's thyroid gland does not produce enough thyroid hormone. This hormone is essential for brain and body development from birth to adulthood. If this hormone is deficient, it leads to delayed physical and mental growth. Early detection and timely supplementation of thyroid hormone within the first two weeks after birth will help the child develop normally.
3.2 G6PD Deficiency 
G6PD deficiency is a condition in which a child’s body cannot produce enough G6PD enzyme. This enzyme is found in red blood cells, and its deficiency leads to the accumulation of harmful substances in red blood cells, making them fragile and prone to breaking. Early detection, avoiding certain medications, and monitoring jaundice in newborns can help prevent hemolytic episodes that may cause anemia and jaundice.
3.3 Congenital Adrenal Hyperplasia 
Congenital adrenal hyperplasia is a disorder caused by abnormal function of the adrenal glands in newborns. This condition can lead to death in severe cases, cause "masculinization" in female infants, and result in early puberty. Early detection allows for more effective treatment with fewer long-term effects on the child’s life.
3.4 Phenylketonuria 
Phenylketonuria is a genetic recessive disorder on chromosome 12, caused by a deficiency in the enzyme Phenylalanine Hydroxylase (PAH). This results in a metabolic disorder that leads to intellectual disabilities, along with cognitive and behavioral abnormalities due to high levels of phenylalanine in the blood,
3,5 Galactosemia 
Galactosemia is a genetic metabolic disorder that impairs the metabolism of the simple sugar galactose, leading to its accumulation in the blood. The condition causes symptoms such as diarrhea, vomiting, seizures, hypoglycemia, and liver cell damage. Early screening helps manage lactose and galactose intake in a child’s diet, preventing life-threatening complications.
4. Why Choose GENTIS for Newborn Screening Tests
Newborn screening should be performed as early as possible to ensure that children grow up healthy and develop normally. Parents should also choose a reputable medical facility for testing.
Currently, GENTIS offers newborn screening for the 5 diseases mentioned. GENTIS is a leading genetic testing center in Vietnam with over 14 years of experience and various certifications, including ISO 15189:2022, ISO 27001:2022, and ISO 9001:2015. GENTIS boasts modern facilities, equipment, and laboratories, along with a team of experts, doctors, and leading consultants.
Let GENTIS help provide the best start for your child!
            [content_more] => 
            [meta_title] => 5 Types of Diseases in Children That Can Be Detected Through Newborn Screening
            [meta_description] => Newborn screening is a test conducted to detect conditions that may affect a child's physical and mental health and development in the future. Let’s explore 5 types of diseases that can be detected early through newborn screening.

            [meta_keyword] => GENTIS,Newborn Screening
            [thumbnail_alt] => 
            [post_id] => 1264
            [category_id] => 4
        )

    [7] => stdClass Object
        (
            [id] => 1263
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => web-hỗ-trợ-sinh-sản-tp.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-12-02
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-12-03 08:46:52
            [updated_time] => 2024-12-03 14:50:00
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => https://gentis.com.vn/tin-tuc-c4/gentis-nha-tai-tro-vang-hoi-thao-khoa-hoc-thuong-nien-lan-thu-5-hasam-2024-d1263
            [title] => GENTIS - A golden sponsor at the 5th annual scientific conference HASAM 2024
            [description] => On December 8, 2024, the 5th annual scientific conference HASAM 2024 with the theme “Updates on advanced in science and technology to enhance the effectiveness of infertility treatment”, organized by the Hanoi Assisted Reproductive Support Association (HASAR) was successfully held at the Pullman hotel, Hanoi. GENTIS was honored to be a sponsor and have a booth showcasing solutions for improving the effectiveness of reproductive support. 
            [content] => 
This year’s annual scientific conference HASAM attracted over 250 delegates including experts, technicians, doctors, etc. currently working in the field of assisted reproduction in order to help them cultivate and interchange experiences in clinical practice, laboratory work, as well as update latest knowledge in treatment, research and technological activities. The symposium went successfully with 28 reports at the main hall and 20 high-quality scientific poster presentations. 

Delegates had chances to present, share and actively discuss, gaining the most recent and in-depth clinical knowledge and experiences in the field of assisted reproduction. The common goal was to enhance the effectiveness of diagnosing and treating infertility, thereby contributing to the improvement of public health care quality.

Attending the symposium this year, Dr. Pham Dinh Minh (Director of R&D department at GENTIS), honorably represented GENTIS to present the report “Research and application of new genetic tests to improve the effectiveness of infertility diagnosis and treatment in Vietnam”. In the report, Dr. Minh emphasized that genetic tests play a crucial role in detecting the causes of infertility and enhancing assisted reproductive treatments. 
The understanding of pathogenesis mechanisms and the development of science and technology has led to many superior diagnostic tests in reproductive support. GENTIS has been researching modern genetic testing technologies that benefit patients, improving the effectiveness in assisted reproduction treatments, including PGT A/SR, PGT-M +100 rare diseases, PGT-Max 1, Karyotype, Fertiscan, Thalassemia, and many more.

Additionally, Dr. Minh also took the role as the Chair of Session B from 10:00 - 12:00 AM, where he led discussions on new knowledge and shared valuable experiences regarding genetic tests beneficial for diagnosing and treating infertility. These contributions aim to bring healthy, happy children to families. 
GENTIS was honored to sponsor the presentation by Assoc. Prof. Dr. Francesca Spinella  (Senior Medical Information Specialist at Eurofins Genoma Group - President of the ESHRE PGT Federation) - Gentis’s senior expert advisor. Her report, titled “Advances in Pre-implantation screening: European perspectives and data from the European Society of Human Reproduction and Embryology (ESHRE)”, provided the Vietnamese medical community with the opportunity to access the latest advancements in pre-implantation screening. 

This year, GENTIS proudly contributed to the success of the conference as a gold sponsor. Attending the event, GENTIS’s expert team had fully observed all scientific sessions and updated the latest knowledge in the field of assisted reproduction with the spirit of continuous learning. 
Additionally, GENTIS’s booth, placed in the exhibition area, received significant attention from delegates. With the help of professional consultants, the genetic tests offered by GENTIS quickly captivated the interest of a large number of attendees. 
GENTIS would like to express our gratitude to the doctors and experts who attended and showed interest with our testing services. With the mission of “Enhancing the physical and intellectual well-being of the Vietnamese people”, GENTIS aims to bring more genetic tests and clinical applications to fertility specialists, contributing to the development of the assisted reproduction field and reproductive health care in Vietnam. Through this, we strive to advance the field of medical genetics to provide the best benefits to patients. 
            [content_more] => 
            [meta_title] => GENTIS - A golden sponsor at the 5th annual scientific conference HASAM 2024
            [meta_description] => On December 8, 2024, HASAM 2024 with the theme “Updates on advanced in science and technology to enhance the effectiveness of infertility treatment”
            [meta_keyword] => gentis,hasam
            [thumbnail_alt] => 
            [post_id] => 1263
            [category_id] => 4
        )

)